SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development

Abstract New genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) constantly emerge through unmitigated spread of the virus in the ongoing Coronavirus disease 2019 pandemic. Omicron (B.1.1.529), the latest variant of concern (VOC), has so far shown exceptional spread and...

Full description

Bibliographic Details
Main Authors:	Danyi Ao, Tianxia Lan, Xuemei He, Jian Liu, Li Chen, Daniel T. Baptista‐Hon, Kang Zhang, Xiawei Wei
Format:	Article
Language:	English
Published:	Wiley 2022-03-01
Series:	MedComm
Subjects:	immune escape Omicron variant spike vaccine development
Online Access:	https://doi.org/10.1002/mco2.126

Similar Items

Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities
by: Mohammad Shah Alam
Published: (2023-02-01)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01)

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
by: Chengbao Ma, et al.
Published: (2022-12-01)

Virological Characteristics of the Omicron Variant: Key Mutations, Pathogenicity, and Immune Escape
by: CHEN Yuqing, et al.
Published: (2023-09-01)

Quantitative Characterization and Prediction of the Binding Determinants and Immune Escape Hotspots for Groups of Broadly Neutralizing Antibodies Against Omicron Variants: Atomistic Modeling of the SARS-CoV-2 Spike Complexes with Antibodies
by: Mohammed Alshahrani, et al.
Published: (2025-02-01)

Prediction of SARS-CoV-2 Omicron Variant Immunogenicity, Immune Escape and Pathogenicity, through the Analysis of Spike Protein-Specific Core Unique Peptides
by: Evangelos Kontopodis, et al.
Published: (2022-02-01)

SARS-CoV-2 omicron spike simulations: broad antibody escape, weakened ACE2 binding, and modest furin cleavage
by: M. Zaki Jawaid, et al.
Published: (2023-10-01)

The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape
by: Weilong Zhang, et al.
Published: (2025-01-01)

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
by: Ailan Xu, et al.
Published: (2022-09-01)

Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape
by: Nash D. Rochman, et al.
Published: (2022-04-01)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
by: Chiranjib Chakraborty, et al.
Published: (2022-02-01)

SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant
by: Cédric Garcia, et al.
Published: (2023-09-01)

Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures
by: Wenxia Shao, et al.
Published: (2022-06-01)

Omicron Spike Protein Has a Positive Electrostatic Surface That Promotes ACE2 Recognition and Antibody Escape
by: Hin Hark Gan, et al.
Published: (2022-06-01)

The Difference in Wave Dynamics between SARS-CoV-2 Pre-Omicron and Omicron Variant Waves
by: Franz Konstantin Fuss, et al.
Published: (2022-12-01)

Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern
by: Hao Yang, et al.
Published: (2022-06-01)

Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
by: Joseph Thomas Ortega, et al.
Published: (2021-12-01)

Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern
by: Ivan Odak, et al.
Published: (2022-03-01)

Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants
by: Matthew R. Chang, et al.
Published: (2022-06-01)

Impacts of delta and omicron variants on inactivated SARS‐CoV‐2 vaccine‐induced T cell responses in patients with autoimmune diseases and healthy controls
by: Shuyi Wang, et al.
Published: (2023-01-01)

The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution
by: Alief Moulana, et al.
Published: (2023-02-01)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
by: Nicholas E. Ingraham, et al.
Published: (2021-12-01)

Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies
by: Hao Zhou, et al.
Published: (2022-06-01)

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2024-07-01)

Adsorption of SARS CoV-2 spike proteins on various functionalized surfaces correlates with the high transmissibility of Delta and Omicron variants
by: Daniela Dobrynin, et al.
Published: (2022-03-01)

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
by: Aleksandr V. Kudriavtsev, et al.
Published: (2022-07-01)

Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis
by: Kaiming Tao, et al.
Published: (2022-08-01)

Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination
by: Almir Ribeiro da Silva Jr, et al.
Published: (2022-02-01)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
by: Maarten E. Emmelot, et al.
Published: (2022-12-01)

Characteristics of Omicron variant-induced SARS-CoV-2 reinfections in Chengdu, China
by: Yingxue DAI, et al.
Published: (2023-04-01)

Comparative Analysis of SARS-CoV-2 Variants of Concern, Including Omicron, Highlights Their Common and Distinctive Amino Acid Substitution Patterns, Especially at the Spike ORF
by: Marios Nikolaidis, et al.
Published: (2022-03-01)

The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
by: Yishan Lu, et al.
Published: (2024-08-01)

Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2
by: Philipp Girl, et al.
Published: (2024-05-01)

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
by: Paola Storti, et al.
Published: (2022-12-01)

Emerging SARS-CoV-2 variants: Why, how, and what's next?
by: Yu Chen, et al.
Published: (2022-06-01)

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
by: Masaud Shah, et al.
Published: (2022-01-01)

Structural impact of a new spike Y170W mutation detected in early emerging SARS-CoV-2 Omicron variants in France
by: Marie Glenet, et al.
Published: (2024-05-01)

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
by: Chanroth Chhoung, et al.
Published: (2024-11-01)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
by: Elisa Regenhardt, et al.
Published: (2023-05-01)

Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health
by: Zepeng Xu, et al.
Published: (2022-06-01)